ACE and diabetes mellitus: In the Diabetes Reduction Approaches with Ramipril and Rosiglitazone Medications (DREAM) study, the effects of the angiotensin-converting enzyme inhibitor ramipril and rosiglitazone on the prevention of diabetes were studied using a two-by-two placebo-controlled design [160].